Results 111 to 120 of about 4,457,527 (301)
Journal of Cosmetic Dermatology, Volume 24, Issue 7, July 2025.ABSTRACT Background More and more people inject fillers to fill their glabellar wrinkles, and complications are on the rise. Case Presentation A 36‐year‐old woman was given a local infiltration anesthetic, and then a 22G sharp needle with an empty syringe was utilized to puncture several times near the subcutaneous tissue to form a tunnel.
Tianqi Shi +6 more
wiley +1 more source
Tissue plasminogen activator dose and pulmonary artery pressure reduction in catheter directed thrombolysis of submassive pulmonary embolism. [PDF]
, 2019 PURPOSE:The purpose of this study is to assess the incremental effect of tissue plasminogen activator (t-PA) dose on pulmonary artery pressure (PAP) and bleeding during catheter directed thrombolysis (CDT) of submassive pulmonary embolism (PE). MATERIALS
Gaba, Ron C +3 more
core +2 more sources
European Journal of Cardio-Thoracic Surgery, 2013 OBJECTIVES The treatment of massive pulmonary embolism (PE) is a matter of debate. We present our institutional experience of patients suffering from massive PE with the aim of comparing the early results, the outcome and quality of life (QoL) between ...
T. Aymard +7 more
semanticscholar +1 more source
Journal of Clinical Nursing, Volume 34, Issue 7, Page 2718-2736, July 2025.ABSTRACT Aim The aim of this study was to (i) identify barriers and enablers and (ii) inform mitigating or strengthening strategies for implementing nurse‐initiated care protocols at scale in emergency departments (EDs). Design Embedded mixed methods. Methods The study included four clusters with a total 29 EDs in NSW, Australia.
Sarah Kourouche +16 more
wiley +1 more source
Intravenous tPA therapy does not worsen acute intracerebral hemorrhage in mice [PDF]
, 2013 Tissue plasminogen activator (tPA) is the only FDA-approved treatment for reperfusing ischemic strokes. But widespread use of tPA is still limited by fears of inadvertently administering tPA in patients with intracerebral hemorrhage (ICH).
Arai, Ken +13 more
core +3 more sources
Local thrombolytic therapy in acute mesenteric ischemia
World Journal of Emergency Surgery, 2013 BackgroundThe aim of the study was to evaluate the local thrombolytic therapy (LTT) in combination with laparoscopy, in management of acute mesenteric ischemia (AMI).MethodsFrom January 2000 to January 2010, patients who were admitted to the hospital ...
F. Yanar +7 more
semanticscholar +1 more source
The origin of thrombolytic therapy
Journal of the American College of Cardiology, 1989 The origin of thrombolytic therapy is briefly reviewed. It began 40 years ago with the demonstration that the injection into patients of a partially purified activator of the native plasminogen-plasmin enzyme system was capable of dissolving clotted blood and fibrinous loculations in the chest.
openaire +3 more sources
Using Tenecteplase for Acute Ischemic Stroke: What Is the Hold Up? [PDF]
, 2020 Alteplase is the only Food and Drug Administration-approved intravenous (IV) thrombolytic medication for acute ischemic stroke. However, multiple recent studies comparing tenecteplase and alteplase suggest that tenecteplase is at least as efficacious as ...
Ataya, Ramsey, Brea, Isabel, Zitek, Tony
core
Clinical benefit of adenosine as an adjunct to reperfusion in ST-elevation myocardial infarction patients: An updated meta-analysis of randomized controlled trials [PDF]
, 2015 Background: Adenosine administered as an adjunct to reperfusion can reduce coronary no-reflow and limit myocardial infarct (MI) size in ST-segment elevation myocardial infarction (STEMI) patients. Whether adjunctive adenosine therapy can improve clinical
Bulluck, Heerajnarain +5 more
core +2 more sources